NICE launches PGD consultation
April 12, 2013 by admin
NICE has launched a consultation of new good practice guidance for patient group directions, with a closing date of 29 April. Only registered stakeholders can comment, so see if your organisation is registered if you would like to be involved.
DH consults on independent prescribing by podiatrists and physiotherapists
October 20, 2011 by admin
Should independent prescribing be extended to podiatrists and physiotherapists? The Department of Health and MHRA have published two consultations with these proposals, which can be found here. The deadline for responses to both is 8 December 2011.
The physiotherapist consultation proposes that physiotherapists can become independent prescribers and that physiotherapist independent prescribers should be able to mix medicines before administration, and direct others to do so, and to prescribe some specified controlled drugs independently. Those physiotherapists who are currently supplementary prescribers would have to undergo additional training to become independent prescribers. The proposals would need changes to the Misuse of Drugs Regulations 2001, as well as to the Medicines Act 1968. Independent prescribing of unlicensed medicines is not included in either document.
The consultation sets out the list of options, ranging from prescribing for any condition from the complete formulary, to prescribing for specified conditions from a specified formulary. The proposals for podiatrists are similar and both consultations give examples of areas where independent prescribing could be useful.
An analysis of the responses to last year’s engagement exercise (see here) is included in the consultations, and shows a lot of support for the option of prescribing for any condition from the full formulary (option 5). The most limited extension - independent prescribing for specified conditions from a specified formulary - found support with the BMA and the Royal College of Physicians, among others. The more limited versions are likely to require frequent revisions to the lists of conditions and/or formularies, a process that those nurses who were prescribing before the formulary was opened up will remember only too well!
GMC consults on prescribing and medicines management guidance
April 28, 2011 by admin
The General Medical Council (GMC) has launched a consultation on its draft guidance, ‘Good practice in prescribing and managing medicines and devices’, which will replace a 2008 version. The consultation closes on 27 May 2011 and anyone with an interest in the issues it raises is welcome to respond.
The draft guidance includes topics such as prescribing for people close to you, prescribing online, conflicts of interest and prescribing off-label and unlicensed medicines.
The future of PGDs - have your say
November 10, 2010 by admin
Do Patient Group Directions (PGDs) prevent professionals getting non-medical prescribing qualifications? Are they now being used to manage planned care? Should they be retained and if so what changes could be made? Do they foster innovation and improvements in care? Are they bureaucratic? Are there other groups of health professionals who should be able to use PGDs? The Medicines and Healthcare products Regulatory Agency (MHRA) has launched an informal consultation about the provisions for PGDs in the NHS and private sector and other related matters and would like responses by 19 November. Revised guidance may accompany any new legislation, as the review offers the opportunity to look at this as well, and to clear up any misunderstandings.